Ultra‐Fast Insulin–Pramlintide Co‐Formulation for Improved Glucose Management in Diabetic Rats-Reference-Cited by-同舟云学术

Ultra‐Fast Insulin–Pramlintide Co‐Formulation for Improved Glucose Management in Diabetic Rats

Published:2021-09-09 Issue:21 Volume:8 Page:2101575
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Adv. Sci.

Author:

Maikawa Caitlin L.¹,Chen Peyton C.¹,Vuong Eric T.¹,Nguyen Leslee T.¹,Mann Joseph L.²,d'Aquino Andrea I.²,Lal Rayhan A.³⁴⁵,Maahs David M.⁴⁵,Buckingham Bruce A.⁴⁵,Appel Eric A.¹²⁴⁵⁶^ORCID

Affiliation:

1. Department of Bioengineering Stanford University Stanford CA 94305 USA

2. Department of Materials Science & Engineering Stanford University Stanford CA 94305 USA

3. Department of Medicine (Endocrinology) Stanford University Stanford CA 94305 USA

4. Department of Pediatrics (Endocrinology) Stanford University Stanford CA 94305 USA

5. Diabetes Research Center Stanford University Stanford CA 94305 USA

6. ChEM‐H Institute Stanford University Stanford CA 94305 USA

Funder

Stanford Diabetes Research Center

Pharmaceutical Research and Manufacturers of America Foundation

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202101575

Reference47 articles.

1. Amylin: Pharmacology, Physiology, and Clinical Potential

2. Adjunctive Therapy with Pramlintide Lowers HbA1c without Concomitant Weight Gain and Increased Risk of Severe Hypoglycemia in Patients with Type 1 Diabetes Approaching Glycemic Targets

3. Amylin replacement with pramlintide as an adjunct to insulin therapy improves long-term glycaemic and weight control in Type 1 diabetes mellitus: a 1-year, randomized controlled trial

4. A Randomized Study and Open-Label Extension Evaluating the Long-Term Efficacy of Pramlintide as an Adjunct to Insulin Therapy in Type 1 Diabetes

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A temperature-responsive dual-hormone foam nanoengine improves rectal absorptivity of insulin-pramlintide for diabetes treatment;Science Advances;2024-08-30

2. Defining Structure-Function Relationships of Amphiphilic Excipients Enables Rational Design of Ultra-Stable Biopharmaceuticals;2024-06-19

3. Oral delivery of the amylin receptor agonist pramlintide;Peptide Science;2024-01-31

4. Oral delivery of the amylin receptor agonist pramlintide;2023-11-13

5. Pramlintide an Adjunct to Insulin Therapy: Challenges and Recent Progress in Delivery;Journal of Pharmacology and Experimental Therapeutics;2023-10-20